Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $887.03 million. The enterprise value is $1.03 billion.
Important Dates
The last earnings date was Wednesday, February 4, 2026, after market close.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Feb 13, 2026 |
Share Statistics
CLB has 46.56 million shares outstanding. The number of shares has decreased by -1.38% in one year.
| Current Share Class | 46.56M |
| Shares Outstanding | 46.56M |
| Shares Change (YoY) | -1.38% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 113.01% |
| Float | 45.94M |
Valuation Ratios
The trailing PE ratio is 27.77 and the forward PE ratio is 25.15. CLB's PEG ratio is 17.23.
| PE Ratio | 27.77 |
| Forward PE | 25.15 |
| PS Ratio | 1.68 |
| Forward PS | n/a |
| PB Ratio | 3.13 |
| P/TBV Ratio | 15.04 |
| P/FCF Ratio | 39.27 |
| P/OCF Ratio | 23.86 |
| PEG Ratio | 17.23 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 14.46, with an EV/FCF ratio of 45.52.
| EV / Earnings | 32.33 |
| EV / Sales | 1.95 |
| EV / EBITDA | 14.46 |
| EV / EBIT | 18.21 |
| EV / FCF | 45.52 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.07 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | 7.26 |
| Interest Coverage | 5.34 |
Financial Efficiency
Return on equity (ROE) is 12.10% and return on invested capital (ROIC) is 9.53%.
| Return on Equity (ROE) | 12.10% |
| Return on Assets (ROA) | 5.94% |
| Return on Invested Capital (ROIC) | 9.53% |
| Return on Capital Employed (ROCE) | 11.53% |
| Weighted Average Cost of Capital (WACC) | 9.35% |
| Revenue Per Employee | $159,552 |
| Profits Per Employee | $9,637 |
| Employee Count | 3,300 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 7.33 |
Taxes
In the past 12 months, CLB has paid $13.37 million in taxes.
| Income Tax | 13.37M |
| Effective Tax Rate | 29.13% |
Stock Price Statistics
The stock price has increased by +6.31% in the last 52 weeks. The beta is 1.09, so CLB's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +6.31% |
| 50-Day Moving Average | 17.63 |
| 200-Day Moving Average | 13.63 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 347,619 |
Short Selling Information
The latest short interest is 4.03 million, so 8.66% of the outstanding shares have been sold short.
| Short Interest | 4.03M |
| Short Previous Month | 4.27M |
| Short % of Shares Out | 8.66% |
| Short % of Float | 8.77% |
| Short Ratio (days to cover) | 11.02 |
Income Statement
In the last 12 months, CLB had revenue of $526.52 million and earned $31.80 million in profits. Earnings per share was $0.68.
| Revenue | 526.52M |
| Gross Profit | 108.93M |
| Operating Income | 56.47M |
| Pretax Income | 45.90M |
| Net Income | 31.80M |
| EBITDA | 71.12M |
| EBIT | 56.47M |
| Earnings Per Share (EPS) | $0.68 |
Full Income Statement Balance Sheet
The company has $22.85 million in cash and $164.02 million in debt, with a net cash position of -$141.17 million or -$3.03 per share.
| Cash & Cash Equivalents | 22.85M |
| Total Debt | 164.02M |
| Net Cash | -141.17M |
| Net Cash Per Share | -$3.03 |
| Equity (Book Value) | 279.76M |
| Book Value Per Share | 5.99 |
| Working Capital | 115.20M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $37.18 million and capital expenditures -$14.59 million, giving a free cash flow of $22.59 million.
| Operating Cash Flow | 37.18M |
| Capital Expenditures | -14.59M |
| Free Cash Flow | 22.59M |
| FCF Per Share | $0.49 |
Full Cash Flow Statement Margins
Gross margin is 20.69%, with operating and profit margins of 10.72% and 6.04%.
| Gross Margin | 20.69% |
| Operating Margin | 10.72% |
| Pretax Margin | 8.72% |
| Profit Margin | 6.04% |
| EBITDA Margin | 13.51% |
| EBIT Margin | 10.72% |
| FCF Margin | 4.29% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.91% |
| Buyback Yield | 1.38% |
| Shareholder Yield | 1.59% |
| Earnings Yield | 3.59% |
| FCF Yield | 2.55% |
Dividend Details Analyst Forecast
The average price target for CLB is $12.50, which is -34.38% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.50 |
| Price Target Difference | -34.38% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |